Genentech’s parent company Roche said the $850m deal lines up with its plan to focus on three therapeutic areas including ...

CDK Global has successfully renewed its DMS agreement with Sonic Automotive, securing a key partnership following two ...

In Hybrids amidst financial challenges. Read More CDK Global extends DMS contract with Sonic Automotive amid cyberattack ...

RHHBY has strengthened its pipeline with an agreement to acquire Regor's portfolio of next-generation CDK inhibitors for the treatment of breast cancer.

Genentech has acquired Regor Pharmaceuticals’ next-generation CDK inhibitors for breast cancer treatment in a deal worth ...

Genentech to buy Regor's portfolio of next-generation CDK inhibitors to treat breast cancer: Cambridge, Massachusetts Tuesday, October 1, 2024, 10:00 Hrs [IST] Regor Pharmaceutica ...

Numa, a startup developing AI-powered automation tech for car dealerships, has raised fresh capital in a Series B round.

As has been widely acknowledged, one of the most meaningful steps a business can take is to establish a single point of ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

A confident update to a grand Arts and Crafts residence learns from the home’s idiosyncratic heritage, responding with ...

We suggest that future therapeutic strategies targeting the oncogenic network of CDK4/6, MEK, PD-L1, and FOXM1 represent ...